跳至主要内容
临床试验/IRCT201108202195N2
IRCT201108202195N2已完成3 期

Evaluation of the effect of IMOD (Setarud) on the National Institute of Health Stroke Scale (NIHSS) in acute ischemic stroke

Vice Chancellor for Research, Tabriz University of Medical Sciences0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 80 years(—)
性别
All

入选标准

  • all patients with acute ischemic stroke (based on clinical and imaging findings)
  • Exclusion criteria: age less than 18years or more than 80 years, prior neurological deficit of any cause, cancer or any other severe disease, rapidly improving symptoms prior to intervention, NIHSS less than 5 at disease presentation, symptom onset less than 3 hours or more than 24 hours, no informed consent, concurrent immunosuppressive / immunomodulator drug use.

排除标准

  • 未提供

研究者

发起方
Vice Chancellor for Research, Tabriz University of Medical Sciences

相似试验